$OMER Draft Agenda PDCO 15-18 October 2019 - European Medicines Agency 2.1.3. Narsoplimab - Orphan - EMEA-002479-PIP01-18 Omeros London Limited; Treatment in haematopoietic stem cell transplantation / Treatment of haematopoietic stem cell transplant associated thrombotic microangiopathy (HSCT-TMA) Day 120 Opinion Action : For adoption Haematology-Hemostaseology ema.europa.eu/en/documents/...
  • 10
10 Likes